Qualigen Therapeutics, Inc.
Hedge Funds Holdings

Last updated:

Qualigen Therapeutics, Inc.‘s stocks are currently a part of 9 hedge funds’ portfolios, which represents 1.66% of the total amount of its stocks outstanding. This makes up a total of 48.64K shares of Qualigen Therapeutics, Inc.. Compared to the previous quarter, the number fell by -72.63% or -129.06K shares fewer. As for the holding position changes, 33.33% (3) of current hedge fund investors increased the number of shares held, 11.11% (1) of current holders sold a part of the shares held, and 11.11% (1) closed the holdings completely. 1 hedge funds are new holders of Qualigen Therapeutics, Inc. stock in Q1 2023, it is 11.11% of total holders.

Hedge funds holding Qualigen Therapeutics (Q2 2020 – Q1 2023)

Number of hedge funds
Q2 2020 8
Q3 2020 15
Q4 2020 25
Q1 2021 29
Q2 2021 27
Q3 2021 27
Q4 2021 25
Q1 2022 28
Q2 2022 23
Q3 2022 23
Q4 2022 13
Q1 2023 9

Hedge funds changes in Qualigen Therapeutics positions (Q2 2020 – Q1 2023)

Changes in positions
Q2 2020 80000
Q3 2020 10313-2
Q4 2020 126322
Q1 2021 107165
Q2 2021 37458
Q3 2021 55548
Q4 2021 43954
Q1 2022 102376
Q2 2022 14666
Q3 2022 240215
Q4 2022 130023-23
Q1 2023 13113

Hedge funds changes in Qualigen Therapeutics stock options (Q2 2020 – Q1 2023)

Changes in stock options
Q2 2020 16,873,000 0
Q3 2020 0 0
Q4 2020 507,000 1,096,000
Q1 2021 205,000 2,140,000
Q2 2021 87,000 102,000
Q3 2021 73,000 21,000
Q4 2021 262,000 8,000
Q1 2022 58,000 0
Q2 2022 75,000 0
Q3 2022 13,000 0
Q4 2022 0 0
Q1 2023 0 0

Top 50 hedge fund holders of Qualigen Therapeutics, Inc. (NASDAQ:QLGN)